Neutra Corp.

NTRR

US64129C3034

Pharmaceuticals

Delayed OTC Markets Other stock markets 10:16:49 11/06/2024 pm IST			5-day change	1st Jan Change
0.0002 ^USD	0.00%		-33.33%	-33.33%

2023	Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	CI
2023	Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	CI

Neutra Corp. Adds Sydney Jim to its Executive Management Team

April 10, 2013 at 02:30 pm IST

Neutra Corp. announced the addition of Sydney Jim to its executive management team April 10, 2013. Mr. Jim will be working alongside CEO Cindy Morrissey, exploring promising new business opportunities in the U.S. medical marijuana (MMJ) industry and other markets.

Since 2011, Mr. Jim has served as Vice President of Business Development for Rockspring Capital.

Latest news about Neutra Corp.

Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2023	16/12	CI
Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2023	15/23/15	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2023	22/23/22	CI
Neutra Corp. Reports Earnings Results for the Full Year Ended January 31, 2023	09/23/09	CI
Neutra Corp. Auditor Raises 'Going Concern' Doubt	09/23/09	CI
Neutra Corp. executed a binding letter of intent to acquire Mercury Clinical Research, Inc.	30/23/30	CI
Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2022	16/22/16	CI
Neutra Corp. Reports Earnings Results for the Second Quarter and Six Months Ended July 31, 2022	15/22/15	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2022	21/22/21	CI
Neutra Corp. Reports Earnings Results for the Full Year Ended January 31, 2022	10/22/10	CI
Neutra Corp. Auditor Raises 'Going Concern' Doubt	10/22/10	CI
Neutra Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended October 31, 2021	10/21/10	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2021	15/21/15	CI
Neutra Corp. acquired Deity Wellness.	23/21/23	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2021	21/21/21	CI
Neutra Corp. Reports Earnings Results for the Third Quarter Ended October 31, 2020	22/20/22	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2020	15/20/15	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2020	14/20/14	CI
Neutra Corp.'s VIVIS Introduces three New Products into the CBD Marketplace	02/20/02	CI
Neutra Corp. announced that it has received funding	01/20/01	CI
Neutra Corp. Reports Earnings Results for the Third Quarter Ended October 31, 2019	24/19/24	CI
Neutra Corp. Reports Earnings Results for the Second Quarter Ended July 31, 2019	24/19/24	CI
Neutra Corp. completed the acquisition of Vivis Corporation from Sydney Jim and others.	10/19/10	CI
Neutra Corp. entered into letter of intent to acquire Vivis Corporation from Sydney Jim and others for $0.04 million.	26/19/26	CI
Neutra Corp. Reports Earnings Results for the First Quarter Ended April 30, 2019	15/19/15	CI

Chart Neutra Corp.

Duration

Period

More charts

Company Profile

Neutra Corp. is an early-stage research and development company. The Company is engaged in marketing and participating in the nutraceutical space by bringing products derived from all natural and organic origins. The Company plans to research and bring new technology to the Nutraceutical space. The Company is primarily focused on participating in the medical cannabis market, which is a nutraceutical sub-market. It intends to entrust the manufacturing to a nutraceutical contractor to private label all of its products and to sell them under its brand. It primarily sells hemp-derived products, including products containing delta-8-THC and other cannabinoids. Its subsidiaries include Diamond Anvil Designs, LLC, Deity Corporation and Vivis Corporation.

Sector

Pharmaceuticals

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
NEUTRA CORP.	-33.33%	6L
ELI LILLY AND COMPANY	+47.42%	78TCr
NOVO NORDISK A/S	+40.67%	63TCr
JOHNSON & JOHNSON	-6.69%	35TCr
MERCK & CO., INC.	+20.34%	33TCr
ABBVIE INC.	+8.39%	30TCr
ASTRAZENECA PLC	+16.75%	25TCr
ROCHE HOLDING AG	-1.19%	22TCr
NOVARTIS AG	+10.85%	21TCr
AMGEN INC.	+4.25%	16TCr